Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care
- 4 January 2018
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 48 (2) , 441-448
Abstract
Background: Cerebral blood volume (CBV) mapping with a dynamic susceptibility contrast (DSC) perfusion technique has become a clinical tool in diagnosing and follow‐up of brain tumors. Ferumoxytol, a long‐circulating iron oxide nanoparticle, has been tested for CBV mapping, but the optimal dose has not been established.Purpose: To compare ferumoxytol DSC of two different doses to standard of care gadoteridol by analyzing time–intensity curves and CBV maps in normal‐appearing brain regions.Study Type: Retrospective.Subjects: Fifty‐four patients with various brain disorders.Field Strength/Sequence: 3T MRI. DSC‐MRI was performed with 0.1 mmol/kg gadoteridol and 1 day later with ferumoxytol in doses of 1 or 2 mg/kg.Assessment: Signal changes during first pass, relative CBV (rCBV) in normal‐appearing thalamus, putamen, and globus pallidus, and contrast‐to‐noise ratio (CNR) of the CBV maps were compared between gadoteridol and various doses of ferumoxytol using an automated method. To subjectively assess the quality of the CBV maps, two blinded readers also assessed visual conspicuity of the putamen.Statistical Tests: Linear mixed effect model was used for statistical comparison.Results: Compared to gadoteridol, 1 mg/kg ferumoxytol showed no difference in CNR (P= 0.6505), peak ΔR2*, and rCBV in the putamen (P= 0.2669, 0.0871) or in the thalamus (P= 0.517, 0.9787); 2 mg/kg ferumoxytol increased peak ΔR2* as well as the CNR (P< 0.0001), but also mildly increased rCBV in putamen and globus pallidus (P= 0.0005, 0.0012). Signal intensities during first pass remained highly above the noise level, with overlapping of 95% confidence intervals with noise only in 3 out of 162 tested regions. Compared to gadoteridol, the visual image quality showed mild improvement with 1 mg/kg (P= 0.02) and marked improvement with 2 mg/kg ferumoxytol (P< 0.0001).Data Conclusion: 1 mg/kg ferumoxytol provides similar imaging results to standard gadoteridol for DSC‐MRI, and 2 mg/kg has a benefit of increased CNR, but may also result in mildly increased rCBV values.Level of Evidence:3Technical Efficacy:Stage 1J. MAGN. RESON. IMAGING 2018;48:441–448.Keywords
Funding Information
- National Institutes of Health (NS053468, CA199111, CA137488‐15S1, 1R25EB016671)
- National Cancer Institute (HHSN261200800001E)
- Walter S. and Lucienne Driskill Foundation
- National Institute of Biomedical Imaging and Bioengineering (1R25EB016671)
This publication has 28 references indexed in Scilit:
- Perfusion MRI: The Five Most Frequently Asked Technical QuestionsAmerican Journal of Roentgenology, 2013
- High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytolMagnetic Resonance in Medicine, 2012
- A Bayesian model of shape and appearance for subcortical brain segmentationNeuroImage, 2011
- Potential for Differentiation of Pseudoprogression From True Tumor Progression With Dynamic Susceptibility-Weighted Contrast-Enhanced Magnetic Resonance Imaging Using Ferumoxytol vs. Gadoteridol: A Pilot StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain TumorsRadiology, 2008
- THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCYNeurosurgery, 2007
- Comparison of cerebral blood volume maps generated fromT2* andT1weighted MRI data in intra-axial cerebral tumoursBritish Journal of Radiology, 2007
- Defining a local arterial input function for perfusion MRI using independent component analysisMagnetic Resonance in Medicine, 2004
- High‐resolution in vivo CBV mapping with MRI in wild‐type miceMagnetic Resonance in Medicine, 2003
- Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain ImagesNeuroImage, 2002